Lake Street Capital initiated coverage on shares of Lantern Pharma (NASDAQ:LTRN – Free Report) in a report released on Wednesday morning, Marketbeat Ratings reports. The firm issued a buy rating and a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback